Ketamine's rapid antidepressant effects have led to a significant increase in off-label psychiatric use, despite the lack of ...

The US Food and Drug Administration (FDA) held a 2-day public hearing this week to solicit input about the marketing and use of medications and medical devices for off-label use. It is fairly common ...

Once promoted as a safer alternative to opioids, the widely prescribed drug is now linked to withdrawal, overdoses and serious side effects that many patients say they were never warned about.

Kevin Outterson is a professor of health law, bioethics, and human rights at the Boston University School of Law. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal.